Fetal Echocardiography and Congenital Heart Disease Screening Across Asia

Congenital heart disease remains the most common serious birth defect across the Asia-Pacific region, affecting roughly eight to ten of every thousand live births. While survival has improved dramatically for many children who undergo timely surgery, outcomes still depend heavily on whether the lesion is recognised before birth. Antenatal detection allows obstetric and neonatal teams to plan delivery at a centre with paediatric cardiac surgery, begin prostaglandin therapy immediately after birth when required, and counsel families with accurate information about prognosis.

In diverse health systems stretching from Tokyo to Manila, and from Sydney to Ulaanbaatar, fetal echocardiography has therefore become a central pillar of perinatal medicine. The discipline sits at the intersection of obstetrics, paediatric cardiology, and maternal-fetal medicine, and remains a recurring theme in regional scientific congresses. As services expand and technologies become more portable, clinicians across Asia are reassessing how best to identify structural cardiac anomalies during pregnancy.

Why Prenatal Cardiac Imaging Matters in the Region

The burden of congenital cardiac disease in Asia is shaped by a combination of genetic predisposition, nutritional factors, and the rising prevalence of maternal conditions such as pregestational diabetes and obesity. Infants born to mothers with poorly controlled diabetes face a five-fold increase in the risk of structural heart defects, and this is well documented in studies summarised in the resource on perinatal outcomes in women with pregestational diabetes. When such lesions are identified antenatally, delivery planning, genetic counselling, and perinatal management can be coordinated in advance.

Detection before birth has been shown to reduce preoperative acidosis, shorten ventilation times, and improve neurological outcomes in severe forms such as hypoplastic left heart syndrome. Beyond the immediate clinical gains, prenatal diagnosis also allows parents time to absorb complex information, meet surgical teams, and make informed decisions about continuation of pregnancy where that is culturally and personally relevant. The emotional and logistical support surrounding a diagnosis is itself a measurable benefit of structured screening programmes.

Techniques and Timing of Fetal Cardiac Assessment

A detailed fetal cardiac study typically combines several sonographic views obtained between 18 and 22 weeks of gestation, though earlier assessment is feasible using transvaginal probes. The four-chamber view remains the foundation of screening, but modern protocols increasingly insist on outflow tract visualisation, three-vessel and trachea views, and assessment of systemic and pulmonary venous return. Each technique adds sensitivity for different lesion categories, and the choice of approach depends on equipment, operator experience, and the clinical indication.

The following comparison summarises the most widely used modalities across the region.

When maternal risk factors are present, including advanced maternal age, pregestational diabetes, or a previously affected child, targeted fetal echocardiography is generally recommended in addition to the standard anomaly scan. Many centres in high-resource systems now follow a stepwise model that begins with first-trimester screening and progresses to detailed study when any suspicion arises.

Variation in Detection Rates Across Asian Centres

Reported antenatal detection rates for congenital heart disease vary widely across the region. Tertiary fetal medicine centres in Japan, South Korea, Singapore, and Australia consistently achieve detection rates above 60 percent for major lesions, with some programmes reporting figures closer to 80 percent. By contrast, many centres in lower-resource settings identify fewer than 20 percent of significant structural heart defects before birth, reflecting differences in scanning time, training pathways, and access to specialist follow-up.

Population-level screening also depends on how widely the four-chamber view is incorporated into routine mid-trimester ultrasound. Where sonographers are trained in outflow tract assessment and where feedback loops exist between obstetric and paediatric cardiology teams, detection improves substantially. Several collaborative networks in Asia have begun sharing imaging protocols and audit data to reduce this variation, an effort that has gained momentum through regional perinatal congresses.

Australia's Integrated Approach to Prenatal Cardiac Care

In Australia, fetal echocardiography is embedded within a publicly funded system that supports routine anomaly scanning under Medicare, alongside specialised tertiary services in cities such as Sydney, Melbourne, Brisbane, and Perth. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists publishes clear indications for referral to fetal medicine units, and the Australian Institute of Health and Welfare tracks perinatal outcomes that allow benchmarking against international peers. Major paediatric cardiac surgical centres, including the Royal Children's Hospital in Melbourne and the Sydney Children's Hospitals Network, accept antenatal referrals from across their respective states.

Indigenous Australian families, particularly those in remote parts of the Northern Territory and Western Australia, have historically experienced reduced access to specialist antenatal services. Outreach sonography, telehealth-supported cardiac review, and partnerships with the Royal Flying Doctor Service have narrowed this gap somewhat, although travel distances in regions such as the Kimberley or Cape York still shape how easily families can attend repeated scans. Cultural safety and continuity of care remain active priorities for services serving Aboriginal and Torres Strait Islander mothers.

Barriers in Low-Resource and Remote Settings

Across much of South and Southeast Asia, and in parts of the Pacific, the barriers to effective fetal cardiac screening are structural as much as clinical. Sonographers may have heavy caseloads, machines may be outdated, and electricity supplies can be unreliable. Where tertiary paediatric cardiac surgery is not available locally, the value of prenatal detection can feel less immediate to clinicians, even though planned delivery at a distant surgical centre still offers survival advantages. Education about the benefits of antenatal diagnosis, and partnerships with regional cardiac surgical hubs, are gradually changing practice.

Broader perinatal research also informs how teams approach pregnancy management in these settings, with resources such as the summary on labor induction methods reflecting the kind of multidisciplinary evidence base that underpins modern perinatal care. Embedding fetal cardiac assessment within this wider framework, rather than treating it as an isolated investigation, helps justify investment in equipment and training. Several international non-governmental organisations have begun sponsoring fellowships that bring sonographers from lower-resource centres to high-volume Asian hubs for hands-on supervised training.

Training, Workforce and Quality Standards

Sustained improvements in detection depend on a workforce that is confident in recognising subtle cardiac signs and knowing when to refer. Formal subspecialty training in maternal-fetal medicine exists in Australia through RANZCOG and dedicated paediatric cardiology fellowships, but many Asian countries rely on shorter diploma courses and in-house mentorship programmes. International societies such as the International Society of Ultrasound in Obstetrics and Gynecology publish teaching curricula, and blended e-learning platforms have made structured training more accessible since the COVID-19 pandemic disrupted in-person conferences.

Quality assurance is equally important. Regular review of false-negative and false-positive findings, correlation with postnatal diagnosis, and feedback from paediatric cardiologists allow services to refine their performance over time. Where such audit loops are absent, individual sonographers may continue to miss lesions that more experienced colleagues would catch. Regional collaborations have begun publishing minimum standards for equipment, scan duration, and image archiving that can be adopted by smaller centres across the region.

Emerging Tools and the Road Ahead

Artificial intelligence-assisted image interpretation, handheld point-of-care ultrasound devices, and spatiotemporal image correlation are reshaping what is possible in fetal cardiac assessment. Smartphone-connected probes now allow screening in remote clinics and field settings, and machine-learning algorithms are being trained to flag suspicious views during routine anomaly scans. These tools may not replace specialist sonographers in the near term, but they can extend the reach of screening into settings where experienced operators are scarce.

For clinicians working in the region, the practical pathway forward involves a combination of clearer referral criteria, ongoing training, and reliable postnatal follow-up. Investment in equipment alone rarely lifts detection rates; it must be paired with curriculum reform, audit, and access to paediatric cardiac surgery. Multidisciplinary engagement across obstetrics, neonatology, and paediatric cardiology remains the cornerstone of any meaningful improvement in antenatal diagnosis.

Clinicians, trainees, and researchers interested in contributing to this evolving field can explore the archived meeting materials and shared resources at the FAOPS 2020 portal to deepen their engagement with regional perinatal science. The site brings together abstracts, speaker sessions, and topic summaries that remain relevant to anyone working in fetal cardiology, obstetrics, or neonatal medicine.

Continued progress will require sustained investment in training, equipment, and referral networks, particularly in lower-resource parts of the region where detection rates lag behind international benchmarks. By sharing protocols, audit data, and fellowship opportunities, the perinatal community in Asia can ensure that more pregnancies complicated by structural heart disease are recognised before birth, allowing families and clinical teams to prepare appropriately for the journey ahead.